MiR-196b-Oct1/2 Axis Regulates DNMT3A-mutant AML Pathogenesis

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2024 Nov 23

PMID 39580581

Authors

Michael E Lawler

Melanie L Goetz

Jennifer S Romer-Seibert

Holly A Gamlen

Edwina McGlinn

Sara E Meyer

Affiliations

Soon will be listed here.

References

Mayle A, Yang L, Rodriguez B, Zhou T, Chang E, Curry C . Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood. 2014; 125(4):629-38. PMC: 4304108. DOI: 10.1182/blood-2014-08-594648. View

Marcucci G, Mrozek K, Radmacher M, Garzon R, Bloomfield C . The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2010; 117(4):1121-9. PMC: 3056468. DOI: 10.1182/blood-2010-09-191312. View

Challen G, Sun D, Jeong M, Luo M, Jelinek J, Berg J . Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011; 44(1):23-31. PMC: 3637952. DOI: 10.1038/ng.1009. View

Tamassia N, Bianchetto-Aguilera F, Gasperini S, Polletti S, Gardiman E, Ostuni R . Induction of OCT2 contributes to regulate the gene expression program in human neutrophils activated via TLR8. Cell Rep. 2021; 35(7):109143. DOI: 10.1016/j.celrep.2021.109143. View

Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S . miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 2012; 3:688. PMC: 3514459. DOI: 10.1038/ncomms1681. View

Ley T, Miller C, Ding L, Raphael B, Mungall A, Robertson A . Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013; 368(22):2059-74. PMC: 3767041. DOI: 10.1056/NEJMoa1301689. View

Wong S, Agarwal V, Mansfield J, Denans N, Schwartz M, Prosser H . Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs. Proc Natl Acad Sci U S A. 2015; 112(35):E4884-93. PMC: 4568285. DOI: 10.1073/pnas.1512655112. View

Bartholdy B, Matthias P . Transcriptional control of B cell development and function. Gene. 2004; 327(1):1-23. DOI: 10.1016/j.gene.2003.11.008. View

Meyer S, Qin T, Muench D, Masuda K, Venkatasubramanian M, Orr E . DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia. Cancer Discov. 2016; 6(5):501-15. PMC: 4861898. DOI: 10.1158/2159-8290.CD-16-0008. View

10.

Patel J, Gonen M, Figueroa M, Fernandez H, Sun Z, Racevskis J . Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012; 366(12):1079-89. PMC: 3545649. DOI: 10.1056/NEJMoa1112304. View

11.

Jafek J, Shakya A, Tai P, Ibarra A, Kim H, Maddox J . Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia. Exp Hematol. 2019; 76:38-48.e2. PMC: 7670548. DOI: 10.1016/j.exphem.2019.07.002. View

12.

Guryanova O, Lieu Y, Garrett-Bakelman F, Spitzer B, Glass J, Shank K . Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells. Leukemia. 2015; 30(5):1133-42. PMC: 4856586. DOI: 10.1038/leu.2015.358. View

13.

Meyer S, Muench D, Rogers A, Newkold T, Orr E, OBrien E . miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med. 2018; 215(8):2115-2136. PMC: 6080909. DOI: 10.1084/jem.20171312. View

14.

Velu C, Chaubey A, Phelan J, Horman S, Wunderlich M, Guzman M . Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. J Clin Invest. 2013; 124(1):222-36. PMC: 3871218. DOI: 10.1172/JCI66005. View

15.

Gamlen H, Romer-Seibert J, Lawler M, Versace A, Goetz M, Feng Y . miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML. Clin Cancer Res. 2022; 28(20):4574-4586. PMC: 9588567. DOI: 10.1158/1078-0432.CCR-22-1598. View